{"id":112708,"date":"2021-04-23T12:04:22","date_gmt":"2021-04-23T12:04:22","guid":{"rendered":"https:\/\/fin2me.com\/?p=112708"},"modified":"2021-04-23T12:04:22","modified_gmt":"2021-04-23T12:04:22","slug":"u-s-cdc-probes-new-death-hospitalization-after-jj-vaccine-shots-officials","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/u-s-cdc-probes-new-death-hospitalization-after-jj-vaccine-shots-officials\/","title":{"rendered":"U.S. CDC probes new death, hospitalization after J&J vaccine shots – officials"},"content":{"rendered":"
(Reuters) -The U.S. Centers for Disease Control and Prevention (CDC) is investigating the death of an Oregon woman and the hospitalization of another in Texas after receiving Johnson & Johnson\u2019s COVID-19 vaccine, state health officials said.<\/p> The incidents come as advisers to the CDC are set to meet on Friday to consider whether it is safe to resume injections of the single-dose vaccine, while senior health officials prepare for a green light.<\/p>\n CDC Director Rochelle Walensky had said on Monday the agency was reviewing reports of a handful of potential cases of severe side effects among people who received the shot, in addition to those that led to a pause in its use.<\/p>\n The CDC notified Oregon about the incident on Tuesday and Texas on Wednesday, the two states\u2019 health officials said.<\/p>\n The Oregon woman, who is in her 50s, received the vaccine before the pause order on its use was issued, the state’s health authority said in a statement. (bit.ly\/32GLvYQ)<\/p>\n She developed \u201ca rare but serious blood clot within two weeks following vaccination,\u201d seen in combination with very low platelets, the Oregon Health Authority added.<\/p>\n It warned that blame could not be assigned until its investigation was complete.<\/p>\n Separately, a woman in Texas who received J&J\u2019s vaccine has been hospitalized for symptoms similar to those of six people who recently suffered blood clots after taking the shot in the United States, a Texas health agency spokesman said.<\/p>\n Last week, U.S. health agencies recommended a pause in the use of the vaccine after six rare cases of blood clots.<\/p>\n On Tuesday, the European Medicines Agency (EMA) said it found a possible link between J&J\u2019s vaccine and rare blood clotting issues in adults who got doses in the United States, but added that the benefits of the shot outweighed the risks.<\/p>\n